China SXT Pharmaceuticals, Inc. (SXTC): Depreciation & Amortization
$73.7K
Year ended 2026-03-31
-33.5%
3-year compound annual growth
-26.6%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2026-03-31 | $73.7K | -10.5% | 2026-07-01, From 2025-04-01 |
| 2025-03-31 | $82.3K | -59.5% | 2026-07-01, From 2024-04-01 |
| 2024-03-31 | $203.2K | -18.8% | 2026-07-01, From 2023-04-01 |
| 2023-03-31 | $250.2K | -21.8% | 2025-07-31, From 2022-04-01 |
| 2022-03-31 | $320.0K | -7.4% | 2024-08-13, From 2021-04-01 |
| 2021-03-31 | $345.4K | +4.1% | 2023-07-31, From 2020-04-01 |
| 2020-03-31 | $331.8K | +83.4% | 2023-05-19, From 2019-04-01 |
| 2019-03-31 | $180.9K | +39.8% | 2021-08-13, From 2018-04-01 |
| 2018-03-31 | $129.4K | n/a | 2020-07-31, From 2017-04-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| China SXT Pharmaceuticals, Inc. (SXTC) | 2026-03-31 | $73.7K | -10.5% |
| Neuphoria Therapeutics Inc. (NEUP) | 2026-06-30 | $663.0K | 0.0% |
| Longeveron Inc. (LGVN) | 2025-12-31 | $800.0K | +14.3% |
| Dare Bioscience, Inc. (DARE) | 2025-12-31 | $1.63M | n/m |
| Vistagen Therapeutics, Inc. (VTGN) | 2026-03-31 | $199.0K | +32.7% |
| IGC Pharma, Inc. (IGC) | 2025-03-31 | $618.0K | -3.0% |
| 60 Degrees Pharmaceuticals, Inc. (SXTP) | 2025-12-31 | $43.3K | +269.5% |
| Shattuck Labs, Inc. (STTK) | 2025-12-31 | $3.70M | -2.6% |
| Cannapharmarx, Inc. (CPMD) | 2024-12-31 | $0 | -100.0% |
Compare SXTC, NEUP, LGVN, DARE side by side · Screen every company in Pharmaceutical Preparations ↗